Pegylatedinterferonalpha-2amonotherapy相关论文
Four-week pegylated interferon α-2a monotherapy for chronic hepatitis C with genotype 2 and low vira
AIM: To assess the efficacy and advantages of 4-wk pegylated interferon α-2a (peg-IFN-α2a) monotherapy for chronic hep......